Thromboembolic Complications in Malignant Haematological Disorders

Roberto Castelli(University of Milan), A Guariglia(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Barbara Ferrari(University of Milan)

Current Vascular Pharmacology

May 22, 2010

10.2174/157016110791330799

Cited by 39

Related Papers

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

|Blood|2009|433

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

|Journal of Clinical Oncology|2016|394

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

|Blood|2014|373

Angiogenesis in myelodysplastic syndromes

|British Journal of Cancer|1999|272

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

|Leukemia|2018|250